News from ICACI 2000: IL-4/IL-5 inhibitor exerts beneficial effects in models of atopic dermatitis Oct. 31, 2000
At least 50% of patients experience clinical benefit with Vasogen's psoriasis candidate Oct. 20, 2000
RSS